WDAF-TV

Elysium Therapeutics to Host Investor Webcast Highlighting SOOPR™ Program and the Need to Address "Fentanyl Rebound" as Key Challenge in the Opioid Overdose Epidemic

LYONS, Colo., May 12, 2025 /PRNewswire/ -- Elysium Therapeutics, an emerging biopharmaceutical company developing treatments specifically designed to rescue and reverse overdoses caused by oral ...
Morningstar

Elysium Therapeutics to Participate in the 2025 BIO International Convention to Discuss Challenge of Fentanyl Rebound and Rescue Medication Designed for Synthetic Opioids

"A major challenge in the opioid overdose crisis is 'fentanyl rebound' requiring re-narcotization, which is the result of a mismatch between the illicit drugs wreaking havoc across our community and ...
KXAN

Elysium Therapeutics' Investor Webcast Highlights "Fentanyl Rebound" as Key Challenge in Reducing Opioid Overdose Hospitalizations and Deaths

LYONS, Colo., June 11, 2025 /PRNewswire/ -- Elysium Therapeutics, an emerging biopharmaceutical company developing treatments specifically designed to rescue and reverse overdoses caused by oral ...